镓68标记的前列腺特异性膜抗原11 PET/MRI与多参数MRI检测前列腺癌的诊断准确性比较
回顾性纳入32例经活检证实前列腺癌、根治性前列腺切除术前接受同期镓68标记的前列腺特异性膜抗原11 PET/MRI的男性,以全组织切片病理为参考标准,按30个解剖区域比较PET/MRI与多参数MRI的敏感度和特异度。PET/MRI区域敏感度优于多参数MRI,特异度两者相似;肿瘤最大标准化摄取值与Gleason评分7分及以上相关。
要点
- 按30个解剖区域评估,PET/MRI区域敏感度高于多参数MRI,特异度两者相似。
- 肿瘤最大标准化摄取值与Gleason评分7分及以上相关(比值比1.71)。
- 采用替代邻近法和广义估计方程两种方式计算区域敏感度和特异度。
核心结论
- 镓68标记的前列腺特异性膜抗原11 PET/MRI检测前列腺癌的敏感度优于多参数MRI。
研究设计与样本
- 回顾性研究,纳入2015年12月至2017年6月间经活检证实前列腺癌、根治性前列腺切除术前接受同期镓68标记的前列腺特异性膜抗原11 PET/MRI的男性32例(中位年龄68岁,四分位距62-71岁)。
- 参考标准为全组织切片病理检查,阅片者对影像学与病理学结果设盲。
- 肿瘤定位基于30个解剖区域,分别计算PET/MRI与多参数MRI的区域敏感度和特异度。
诊断标准与关键数值
- 采用替代邻近法,PET/MRI区域敏感度74%(95%CI:70%,77%)vs 多参数MRI 50%(95%CI:45%,0.54%),P < .001。
- 采用广义估计方程群体平均估计,PET/MRI区域敏感度73%(95%CI:68%,79%)vs 多参数MRI 69%(95%CI:62%,75%),P = .04。
- 采用替代邻近法,PET/MRI区域特异度88%(95%CI:85%,91%)vs 多参数MRI 90%(95%CI:87%,92%),P = .99。
- 群体平均估计中,PET/MRI区域特异度70%(95%CI:64%,76%)vs 多参数MRI 70%(95%CI:64%,75%),P = .99。
- 肿瘤最大标准化摄取值与Gleason评分7分及以上相关,比值比1.71(95%CI:1.27,2.31),P < .001。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To compare the diagnostic accuracy of gallium 68 (68Ga)-labeled prostate-specific membrane antigen (PSMA)-11 PET/MRI with that of multiparametric MRI in the detection of prostate cancer. Materials and Methods The authors performed a retrospective study of men with biopsy-proven prostate cancer who underwent simultaneous 68Ga-PSMA-11 PET/MRI before radical prostatectomy between December 2015 and June 2017. The reference standard was whole-mount pathologic examination. Readers were blinded to radiologic and pathologic findings. Tumor localization was based on 30 anatomic regions. Region-specific sensitivity and specificity were calculated for PET/MRI and multiparametric MRI by using raw stringent and alternative neighboring approaches. Maximum standardized uptake value (SUVmax) in the tumor and Prostate Imaging Reporting and Data System (PI-RADS) version 2 grade were compared with tumor Gleason score. Generalized estimating equations were used to estimate population-averaged sensitivity and specificity and to determine the association between tumor characteristics and SUVmax or PI-RADS score. Results Thirty-two men (median age, 68 years; interquartile range: 62-71 years) were imaged. The region-specific sensitivities of PET/MRI and multiparametric MRI were 74% (95% confidence interval [CI]: 70%, 77%) and 50% (95% CI: 45%, 0.54%), respectively, with the alternative neighboring approach (P < .001 for both) and 73% (95% CI: 68%, 79%) and 69% (95% CI: 62%, 75%), respectively, with the population-averaged generalized estimating equation (P = .04). Region-specific specificity of PET/MRI was similar to that of multiparametric MRI with the alternative neighboring approach (88% [95% CI: 85%, 91%] vs 90% [95% CI: 87%, 92%], P = .99) and in population-averaged estimates (70% [95% CI: 64%, 76%] vs 70% [95% CI: 64%, 75%], P = .99). SUVmax was associated with a Gleason score of 7 and higher (odds ratio: 1.71 [95% CI: 1.27, 2.31], P < .001). Conclusion The sensitivity of gallium 68-labeled prostate-specific membrane antigen-11 PET/MRI in the detection of prostate cancer is better than that of multiparametric MRI. © RSNA, 2018 See also the editorial by Civelek in this issue.
引用
- Hicks RM, Simko JP, Westphalen AC, et al. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018. PMID: 30226456. doi:10.1148/radiol.2018180788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。